“…Due to the loss of live HCC cells led by CPR, it is considered a reliable indicator of a favorable prognosis after LT [ 34 ]. Follow-up data from Kim MJ et al [ 33 ] also confirmed significantly lower HCC recurrence rates at 1, 3, and 5 years in CPR patients compared to pre-LT partial pathological response (PPR) patients (5.1%, 7.6%, and 7.6% vs. 15.3%, 20.9%, and 25.4%, p < 0.001). Importantly, preoperative PIVKA-II levels were significantly lower than those of patients in the PPR group (mean ± SD: 46.7 ± 126.2 vs. 77.4 ± 164.4, p < 0.001), and receiver operating characteristic curve analysis showed that the critical value of PIVKA-II between the two groups was 29 mAu/mL.…”